Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Drexel H, Rein P, Hostalek U, Kastelein J
Clinical Experience With Prolonged-Release Nicotinic Acid in Statin-Treated Patients Managed in the Usual-Care Setting in Austria: An Analysis from Niaspan®-Induced HDL-Elevation for Optimizing Risk Control (NEMO) Study
Journal of Clinical and Basic Cardiology 2007; 10 (1-4): 7-10

PDF    Summary    Overview   

This Image - Fig. 1: NEMO study Fig. 2: Lipid profiles
Figure/Graphic 1: NEMO study
Incidences of flushing during the NEMO study. Percentages refer to overall populations (n = 220 for the Austrian population and n = 1053 for the overall population). The severity of flushes was rated by study investigators.
 
NEMO study
Previous ImageNext Image   


Figure/Graphic 1: NEMO study
Incidences of flushing during the NEMO study. Percentages refer to overall populations (n = 220 for the Austrian population and n = 1053 for the overall population). The severity of flushes was rated by study investigators.
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung